Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TEKTURNA HCT

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Standard Dose
EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TEKTURNA HCT is listed in Drugs@FDA under application 022107 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NODEN PHARMA Submission history Latest submission status date: 2020-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TEKTURNA HCT is listed in Drugs@FDA under application 022107 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NODEN PHARMA Submission history Latest submission status date: 2020-09-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.